These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21062151)

  • 1. Cancer genome sequencing and potential application in oncology.
    Katsios C; Zoras O; Roukos DH
    Future Oncol; 2010 Oct; 6(10):1527-31. PubMed ID: 21062151
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.
    Horswell S; Matthews N; Swanton C
    Cancer Lett; 2013 Nov; 340(2):220-6. PubMed ID: 23142290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steering cancer genomics into the fast lane.
    Pennisi E
    Science; 2013 Mar; 339(6127):1540-2. PubMed ID: 23539592
    [No Abstract]   [Full Text] [Related]  

  • 4. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic alterations as the basis for resistance to targeted therapies.
    Blair BG; Bardelli A; Park BH
    J Pathol; 2014 Jan; 232(2):244-54. PubMed ID: 24114654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the human genome in cancer with genomic approaches.
    Scheel JR; Kuo MD
    J Vasc Interv Radiol; 2006 Aug; 17(8):1225-33. PubMed ID: 16923971
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer omics: from regulatory networks to clinical outcomes.
    Tang B; Hsu PY; Huang TH; Jin VX
    Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing technologies for DNA methylation analyses in cancer genomics.
    Boerno ST; Grimm C; Lehrach H; Schweiger MR
    Epigenomics; 2010 Apr; 2(2):199-207. PubMed ID: 22121870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolomics and its application in malignant tumors].
    Ou-Yang J; Wu MH; Huang C; Li D; Zhou M; Li XL; Li GY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):221-5. PubMed ID: 17478926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Normal' genes key to cancer growth.
    Check Hayden E
    Nature; 2008 Feb; 451(7179):615. PubMed ID: 18256629
    [No Abstract]   [Full Text] [Related]  

  • 11. Next generation sequencing applications in cancer research.
    Zhang W; Nykter M; Chen K
    Cancer Lett; 2013 Nov; 340(2):149-50. PubMed ID: 23764479
    [No Abstract]   [Full Text] [Related]  

  • 12. Designing transformative clinical trials in the cancer genome era.
    Sleijfer S; Bogaerts J; Siu LL
    J Clin Oncol; 2013 May; 31(15):1834-41. PubMed ID: 23589555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
    Smith L; Lind MJ; Welham KJ; Cawkwell L;
    Cancer; 2006 Jul; 107(2):232-41. PubMed ID: 16752413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genome sequencing for personalized cancer treatment].
    Skotheim RI; Meza-Zepeda LA; Hovig E; Lønning PE; Lothe RA; Myklebost O
    Tidsskr Nor Laegeforen; 2012 Nov; 132(21):2406-8. PubMed ID: 23160594
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive genome sequencing of the liver cancer genome.
    Nakagawa H; Shibata T
    Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistatic interactions and drug response.
    Weigelt B; Reis-Filho JS
    J Pathol; 2014 Jan; 232(2):255-63. PubMed ID: 24105606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing takes centre stage in cancer profiling.
    Maher B
    Nature; 2009 May; 459(7244):146-7. PubMed ID: 19444175
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomic analysis from tissue core biopsies: standard of care for the future?
    Sarkar S; Tuck DP; Harris LN
    Breast Cancer Res Treat; 2009 Dec; 118(3):645-6. PubMed ID: 19234784
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics.
    Lee AJ; Swanton C
    Biochem Pharmacol; 2012 Apr; 83(8):1013-20. PubMed ID: 22192819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.